H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 91 Citations 26,690 330 World Ranking 163 National Ranking 4
Medicine D-index 88 Citations 25,028 312 World Ranking 6478 National Ranking 194

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Antibody
  • Immune system

Virology, Epitope, Glycoprotein, Antibody and Glycan are his primary areas of study. His Virology research integrates issues from Recombinant DNA and Antigen. He has included themes like Protein structure, Molecular biology, Antigenicity and Immunogenicity in his Epitope study.

His work carried out in the field of Glycoprotein brings together such families of science as Glycoprotein complex, Peptide sequence, Mutant and Protomer. His Antibody research is within the category of Immunology. His biological study spans a wide range of topics, including Glycosylation, Binding site and Cell biology.

His most cited work include:

  • Crystal structure of a soluble cleaved HIV-1 envelope trimer. (671 citations)
  • A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies (623 citations)
  • A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies (623 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Virology, Antibody, Glycoprotein, Epitope and Glycan. His Virology research incorporates themes from Immunization, Gp41 and Immunogenicity. He combines subjects such as Immune system and Antigen with his study of Antibody.

His Glycoprotein research includes elements of Glycoprotein complex, Immunogen, Recombinant DNA and Hiv 1 envelope. His study looks at the relationship between Epitope and fields such as Protein structure, as well as how they intersect with chemical problems. His Glycan study integrates concerns from other disciplines, such as Glycosylation and Cell biology.

He most often published in these fields:

  • Virology (105.80%)
  • Antibody (94.93%)
  • Glycoprotein (74.64%)

What were the highlights of his more recent work (between 2019-2021)?

  • Antibody (94.93%)
  • Virology (105.80%)
  • Epitope (65.22%)

In recent papers he was focusing on the following fields of study:

Rogier W. Sanders spends much of his time researching Antibody, Virology, Epitope, Neutralization and Glycoprotein. The concepts of his Antibody study are interwoven with issues in Antigen, Severe acute respiratory syndrome coronavirus 2, Virus, Cell biology and Coronavirus. His Antigen study combines topics from a wide range of disciplines, such as Biophysics and Immune system.

His Virology research is multidisciplinary, incorporating elements of Immunization, Monoclonal antibody and Immunity. His work deals with themes such as Metabolite, Tetrapyrrole, Immunogenicity and Glycan, which intersect with Epitope. His work in Glycoprotein covers topics such as Viral Vaccine which are related to areas like Protein engineering.

Between 2019 and 2021, his most popular works were:

  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. (463 citations)
  • Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. (463 citations)
  • An Alternative Binding Mode of IGHV3-53 Antibodies to the SARS-CoV-2 Receptor Binding Domain. (55 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Immune system

Rogier W. Sanders focuses on Antibody, Virology, Glycoprotein, Antigen and Epitope. His studies in Antibody integrate themes in fields like Severe acute respiratory syndrome coronavirus 2, Virus, Receptor binding site, Glycan and Cell biology. His research integrates issues of Viral envelope, Glycosylation, Receptor and Gp41 in his study of Glycan.

The various areas that Rogier W. Sanders examines in his Virology study include Monoclonal antibody and Coronavirus. His Glycoprotein research includes themes of Biophysics, Neutralizing antibody and Immunogenicity. Rogier W. Sanders does research in Epitope, focusing on Epitope mapping specifically.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.

Rogier W. Sanders;Miro Venturi;Linnea Schiffner;Roopa Kalyanaraman.
Journal of Virology (2002)

792 Citations

Crystal structure of a soluble cleaved HIV-1 envelope trimer.

Jean-Philippe Julien;Albert Cupo;Devin Sok;Devin Sok;Robyn L. Stanfield;Robyn L. Stanfield.
Science (2013)

786 Citations

A Recombinant Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Complex Stabilized by an Intermolecular Disulfide Bond between the gp120 and gp41 Subunits Is an Antigenic Mimic of the Trimeric Virion-Associated Structure

James M. Binley;Rogier W. Sanders;Brian Clas;Norbert Schuelke.
Journal of Virology (2000)

735 Citations

A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield

Robert Pejchal;Katie J. Doores;Katie J. Doores;Laura M. Walker;Reza Khayat.
Science (2011)

722 Citations

A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

Rogier W. Sanders;Rogier W. Sanders;Ronald Derking;Albert Cupo;Jean-Philippe Julien.
PLOS Pathogens (2013)

690 Citations

Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

Dmitry Lyumkis;Jean-Philippe Julien;Natalia de Val;Albert Cupo.
Science (2013)

677 Citations

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies.

Nicole A. Doria-Rose;Chaim A. Schramm;Jason Gorman;Penny L. Moore.
Nature (2014)

616 Citations

Stabilization of the Soluble, Cleaved, Trimeric Form of the Envelope Glycoprotein Complex of Human Immunodeficiency Virus Type 1

Rogier W. Sanders;Mika Vesanen;Norbert Schuelke;Aditi Master.
Journal of Virology (2002)

585 Citations

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability.

Philip J. M. Brouwer;Tom G. Caniels;Karlijn van der Straten;Jonne L. Snitselaar.
Science (2020)

463 Citations

HIV-1 neutralizing antibodies induced by native-like envelope trimers

Rogier W. Sanders;Rogier W. Sanders;Marit J. Van Gils;Ronald Derking;Devin Sok;Devin Sok.
Science (2015)

413 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rogier W. Sanders

Dennis R. Burton

Dennis R. Burton

Scripps Research Institute

Publications: 237

David C. Montefiori

David C. Montefiori

Duke University

Publications: 224

Barton F. Haynes

Barton F. Haynes

Duke University

Publications: 208

John R. Mascola

John R. Mascola

National Institutes of Health

Publications: 176

Peter D. Kwong

Peter D. Kwong

National Institutes of Health

Publications: 169

Andrew B. Ward

Andrew B. Ward

Scripps Research Institute

Publications: 166

Lynn Morris

Lynn Morris

University of the Witwatersrand

Publications: 151

Michel C. Nussenzweig

Michel C. Nussenzweig

Rockefeller University

Publications: 151

Ian A. Wilson

Ian A. Wilson

Scripps Research Institute

Publications: 143

Penny L. Moore

Penny L. Moore

National Health Laboratory Service

Publications: 133

Leonidas Stamatatos

Leonidas Stamatatos

Fred Hutchinson Cancer Research Center

Publications: 110

Michael S. Seaman

Michael S. Seaman

Beth Israel Deaconess Medical Center

Publications: 109

Shane Crotty

Shane Crotty

La Jolla Institute For Allergy & Immunology

Publications: 102

Richard T. Wyatt

Richard T. Wyatt

Scripps Research Institute

Publications: 99

William R. Schief

William R. Schief

Scripps Research Institute

Publications: 95

Celia C. LaBranche

Celia C. LaBranche

Duke University

Publications: 92

Something went wrong. Please try again later.